NCT05053074View on ClinicalTrials.gov

Nasal High Flow (NHF) in COPD - Effects on Ventilation in Wakefulness

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 27, 2021

Primary Completion Date

November 12, 2021

Study Completion Date

March 1, 2022

Conditions
COPD
Interventions
DEVICE

Nasal High Flow (NHF)

Patients with chronic respiratory failure are treated for 1 h with NHF therapy and with individual O2 supplementation during wakefulness.

Trial Locations (1)

45276

Evang. Kliniken Essen-Mitte gGmbH, Essen

All Listed Sponsors
lead

Institut für Pneumologie Hagen Ambrock eV

INDUSTRY

NCT05053074 - Nasal High Flow (NHF) in COPD - Effects on Ventilation in Wakefulness | Biotech Hunter | Biotech Hunter